NDAOPHTHALMICOINTMENT
Lifecycle
Pre-Launch
Data completeness
0/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHLOROMYXIN is a fixed-dose combination ophthalmic ointment containing chloramphenicol and polymyxin B sulfate, designed for topical ocular use. This dual-agent formulation targets bacterial eye infections by combining a broad-spectrum antibiotic (chloramphenicol) with a polymyxin-class agent. The product addresses unmet needs in ophthalmic bacterial infection treatment with a convenient ointment delivery system.
Pre-Launch
As a pre-launch asset, this product is in early commercialization planning phase with opportunity for team expansion across manufacturing, regulatory, and commercial functions.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CHLOROMYXIN, as a Pfizer pre-launch ophthalmic product, offers entry-level and mid-career professionals the opportunity to participate in bringing a new-to-market combination therapy to launch. Working on this asset provides exposure to ophthalmic market dynamics, regulatory submission strategy, and field commercialization of a specialty topical product.
Brand ManagerField Sales Representative
Worked on CHLOROMYXIN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.